Cost-effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in HIV patients initiating first-line antiretroviral therapy

Detalles Bibliográficos
Autores principales: Broder, MS, Juday, T, Uy, J, Chang, EY, Bentley, TGK
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The International AIDS Society 2010
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113021/
http://dx.doi.org/10.1186/1758-2652-13-S4-P234
_version_ 1782205870122205184
author Broder, MS
Juday, T
Uy, J
Chang, EY
Bentley, TGK
author_facet Broder, MS
Juday, T
Uy, J
Chang, EY
Bentley, TGK
author_sort Broder, MS
collection PubMed
description
format Online
Article
Text
id pubmed-3113021
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher The International AIDS Society
record_format MEDLINE/PubMed
spelling pubmed-31130212011-06-13 Cost-effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in HIV patients initiating first-line antiretroviral therapy Broder, MS Juday, T Uy, J Chang, EY Bentley, TGK J Int AIDS Soc Poster Presentation The International AIDS Society 2010-11-08 /pmc/articles/PMC3113021/ http://dx.doi.org/10.1186/1758-2652-13-S4-P234 Text en Copyright ©2010 Juday et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Broder, MS
Juday, T
Uy, J
Chang, EY
Bentley, TGK
Cost-effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in HIV patients initiating first-line antiretroviral therapy
title Cost-effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in HIV patients initiating first-line antiretroviral therapy
title_full Cost-effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in HIV patients initiating first-line antiretroviral therapy
title_fullStr Cost-effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in HIV patients initiating first-line antiretroviral therapy
title_full_unstemmed Cost-effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in HIV patients initiating first-line antiretroviral therapy
title_short Cost-effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in HIV patients initiating first-line antiretroviral therapy
title_sort cost-effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in hiv patients initiating first-line antiretroviral therapy
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113021/
http://dx.doi.org/10.1186/1758-2652-13-S4-P234
work_keys_str_mv AT broderms costeffectivenessofatazanavirritonavirversuslopinavirritonavirinhivpatientsinitiatingfirstlineantiretroviraltherapy
AT judayt costeffectivenessofatazanavirritonavirversuslopinavirritonavirinhivpatientsinitiatingfirstlineantiretroviraltherapy
AT uyj costeffectivenessofatazanavirritonavirversuslopinavirritonavirinhivpatientsinitiatingfirstlineantiretroviraltherapy
AT changey costeffectivenessofatazanavirritonavirversuslopinavirritonavirinhivpatientsinitiatingfirstlineantiretroviraltherapy
AT bentleytgk costeffectivenessofatazanavirritonavirversuslopinavirritonavirinhivpatientsinitiatingfirstlineantiretroviraltherapy

Ejemplares similares